Provided by Tiger Trade Technology Pte. Ltd.

Alpha Tau Medical

6.86
-0.0400-0.58%
Post-market: 6.990.1300+1.90%18:36 EDT
Volume:236.33K
Turnover:1.61M
Market Cap:603.75M
PE:-12.94
High:7.02
Open:6.82
Low:6.60
Close:6.90
52wk High:8.60
52wk Low:2.30
Shares:88.01M
Float Shares:57.35M
Volume Ratio:1.27
T/O Rate:0.41%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.5300
EPS(LYR):-0.5300
ROE:-61.00%
ROA:-27.55%
PB:7.83
PE(LYR):-12.94

Loading ...

Japan MHLW Grants Shonin Marketing Approval for Alpha Tau’s Alpha DaRT in Head and Neck Cancer

Reuters
·
Feb 24

Alpha Tau issues letter to shareholders

TIPRANKS
·
Jan 29

Alpha Tau Medical Ltd - Ramping U.S. Manufacturing for Commercial Readiness

THOMSON REUTERS
·
Jan 29

Alpha Tau Medical Ltd. Publishes Shareholder Letter Covering Fiscal Year 2025

Reuters
·
Jan 29

BRIEF-Alpha Tau Reports New Positive Results In Two Upcoming Presentations

Reuters
·
Jan 06

Alpha Tau Medical Reports 81% Disease Control Rate in Pancreatic Cancer Alpha DaRT Study

Reuters
·
Jan 06

Alpha Tau Reports New Positive Results in Two Upcoming Presentations at Asco Gi 2026 Symposium Showcasing Immune-Preservation and High Disease Control in Montreal Pancreatic Cancer Alpha Dart® Study

THOMSON REUTERS
·
Jan 06

BRIEF-Alpha Tau Submits First Pre-Market Approval Module To The FDA

Reuters
·
Jan 05

FDA Begins Modular Review of Alpha Tau’s Alpha DaRT for Recurrent cSCC

Reuters
·
Jan 05

Alpha Tau Submits First Pre-Market Approval Module to the FDA for Alpha Dart® for the Treatment of Recurrent Cutaneous Squamous Cell Carcinoma (Cscc)

THOMSON REUTERS
·
Jan 05

Alpha Tau Medical to Present Corporate Update at J.P. Morgan Healthcare Conference

Reuters
·
Dec 18, 2025

Is Alpha Tau Medical (NASDAQ:DRTS) Using Debt Sensibly?

Simply Wall St.
·
Dec 11, 2025

Alpha Tau Medical Up Over 12%, on Track for Highest Close Since January 2023 -- Data Talk

Dow Jones
·
Dec 11, 2025

Alpha Tau Medical Is Maintained at Buy by Citigroup

Dow Jones
·
Dec 11, 2025

Alpha Tau Medical Ltd - Treats First Patient in Glioblastoma Study

THOMSON REUTERS
·
Dec 09, 2025

Alpha Tau Medical Treats First Glioblastoma Patient with Alpha DaRT in U.S. Trial

Reuters
·
Dec 09, 2025

Alpha Tau Medical Launches U.S. Clinical Trial of Alpha DaRT for Pancreatic Cancer

Reuters
·
Dec 04, 2025

Alpha Tau Medical Wins FDA Approval to Begin Prostate Cancer Trial

Reuters
·
Dec 02, 2025

Alpha Tau Receives FDA Approval to Initiate a Trial for Patients With Locally Recurrent Prostate Cancer

THOMSON REUTERS
·
Dec 02, 2025

Alpha Tau to Participate in December Investor Conferences

GlobeNewswire
·
Dec 01, 2025